7314 Federal Register / Vol. 73, No. 26 / Thursday, February 7, 2008 / Notices 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Jose H. Guerrier, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5222, 

MSC 7852, Bethesda, MD 20892, 301–435–

1137, guerriej@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Hypertension and Vascular Smooth Muscle 

Function. 

Date: March 17, 2008. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Rajiv Kumar, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4122, 

MSC 7802, Bethesda, MD 20892, 301–435–

1212, kumarra@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Fellowships: Physiology and Pathobiology of 

Organ Systems. 

Date: March 18, 2008. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Abdelouahab Aitouche, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2183, 

MSC 7818, Bethesda, MD 20892, 301–435–

2365, abdelouiahaba@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Biophysical 

and Biochemical Science. 

Date: March 18–19, 2008. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Bethesda Hotel, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Denise Beusen, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4142, 

MSC 7806, Bethesda, MD 20892, (301) 435–

1267, beusend@csr.nih.gov. 

Name of Committee: AIDS and Related 

Research Integrated Review Group, AIDS 

Immunology and Pathogenesis Study 

Section. 

Date: March 18, 2008. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont, 2401 M Street, NW., 

Washington, DC 20037. 

Contact Person: Shiv A. Prasad, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5220, 

MSC 7852, Bethesda, MD 20892, 301–443–

5779, prasads@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Lymphatic 

Biology in Health and Disease. 

Date: March 18–19, 2008. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Maqsood A. Wani, PhD, 

DVM, Scientific Review Administrator, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 2114, MSC 7814, Bethesda, MD 20892, 

301–445–2270, wanimaqs@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Fellowships: Diversity Program. 

Date: March 19, 2008. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Bonnie L. Burgess-Beusse, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2191C, 

MSC 7818, Bethesda, MD 20892, 301–435–

1783, beusseb@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Biobehavioral Mechanisms of 

Emotion, Stress and Health. 

Date: March 19, 2008. 

Time: 3 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Biao Tian, PhD, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 3089B, MSC 7848, 

Bethesda, MD 20892, 301–402–4411, 

tianbi@csr.nih.gov. 

Name of Committee: AIDS and Related 

Research Integrated Review Group, AIDSassociated Opportunistic Infections and 

Cancer Study Section. 

Date: March 20, 2008. 

Time: 8 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Eduardo A. Montalvo, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5212, 

MSC 7852, Bethesda, MD 20892, (301) 435–

1168, montalve@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Filament 

Contraction. 

Date: March 20, 2008. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Russell T. Dowell, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4128, 

MSC 7814, Bethesda, MD 20892, (301) 435–

1850, dowellr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Angiogenesis and Vasculogenesis. 

Date: March 31, 2008. 

Time: 2:30 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Maqsood A. Wani, PhD, 

DVM., Scientific Review Administrator, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 2114, MSC 7814, Bethesda, MD 20892, 

301–435–2270, wanimaqs@csr.nih.gov. 

(Catalogue of Federal Assistance Program 

Nos. 93.306, Comparative Medicine; 93.333, 

Clinical Research, 93.306, 93.333, 93.337, 

93.393–93.396, 93.837–93.844, 93.846–

93.878, 93.892, 93.893, National Institutes of 

Health, HHS) 

January 31, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–518 Filed 2–6–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2008–0029] 

Lower Mississippi River Waterway 

Safety Advisory Committee; Meeting 

AGENCY: Coast Guard, DHS. 

ACTION: Notice of meeting. 

SUMMARY: The Lower Mississippi River 

Waterway Safety Advisory Committee 

will meet in New Orleans to discuss 

various issues relating to navigational 

safety on the Lower Mississippi River 

and related waterways. This meeting 

will be open to the public. 

DATES: The Committee will meet on 

Thursday, March 20, 2008 from 9 a.m. 

to 12 p.m. This meeting may close early 

if all business is finished. Written 

material and requests to make oral 

presentations should reach the Coast 

Guard on or before March 6, 2008. 

Requests to have a copy of your material 

distributed to each member of the 

committee or subcommittee should 

reach the Coast Guard on or before 

March 6, 2008. 

ADDRESSES: The Committee will meet at 

the New Orleans Yacht Club, 403 North 

Roadway, West End, New Orleans, LA 


jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 73, No. 26 / Thursday, February 7, 2008 / Notices 7315 

70124. Send written material and 

requests to make oral presentations to 

Commanding Officer, Executive Director 

of Lower Mississippi River Waterway 

Safety Advisory Committee; USCG 

Sector New Orleans ATTN: Waterways 

Management, 1615 Poydras St., New 

Orleans, LA 70112. This notice is 

available in our online docket, USCG–

2008–0029 at http:// 

www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

LT Tonya Harrington, Assistant to 

Executive Director of Lower Mississippi 

River Waterway Safety Advisory 

Committee; at 504–565–5108. 

SUPPLEMENTARY INFORMATION: Notice of 

this meeting is given under the Federal 

Advisory Committee Act, 5 U.S.C. App. 

(Pub. L. 92–463). 

Agenda of Meeting 

The agenda for the March 20, 2008 

Committee meeting is as follows: 

(1) Introduction of committee 

members. 

(2) Opening Remarks. 

(3) Approval of the December 11, 

2007 minutes. 

(4) Old Business. 

(a) Captain of the Port status report. 

(b) VTS update report. 

(c) Subcommittee/Working Groups 

update reports. 

(5) New Business. 

(6) Adjournment. 

Procedural 

This meeting is open to the public. 

Please note that the meeting may close 

early if all business is finished. At the 

Chair’s discretion, members of the 

public may make oral presentations 

during the meeting. If you would like to 

make an oral presentation at a meeting, 

please notify the Executive Director no 

later than March 6, 2008. Written 

material for distribution at a meeting 

should reach the Coast Guard no later 

than March 6, 2008. If you would like 

a copy of your material distributed to 

each member of the committee or 

subcommittee in advance of a meeting, 

please submit 25 copies to the Executive 

Director no later than March 6, 2008. 

Information on Services for Individuals 

With Disabilities 

For information on facilities or 

services for individuals with disabilities 

or to request special assistance at the 

meeting, contact the Executive Director 

as soon as possible. 

Dated: January 24, 2008. 

J.H. Korn, 

Captain, U.S. Coast Guard, Commander, 8th 

Coast Guard Dist., Acting. 

[FR Doc. E8–2208 Filed 2–6–08; 8:45 am] 

BILLING CODE 4910–15–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Bureau of Customs and Border 

Protection 

[USCBP–2007–0083] 

Proposed Interpretation of the 

Expression ‘‘Sold for Exportation to 

the United States’’ for Purposes of 

Applying the Transaction Value 

Method of Valuation in a Series of 

Sales 

AGENCY: Customs and Border Protection, 

Department of Homeland Security. 

ACTION: Proposed interpretation; 

extension of comment period. 

SUMMARY: This document provides an 

additional 30 days for interested parties 

to submit comments on Customs and 

Border Protection’s proposed 

interpretation of the phrase ‘‘sold for 

exportation to the United States’’ for 

purposes of applying the transaction 

value method of valuation in a series of 

sales importation scenario. The 

proposed interpretation was published 

in the Federal Register on January 24, 

2008, and the comment period was 

scheduled to expire on March 24, 2008. 

DATES: Comments on the proposed rule 

must be received on or before April 23, 

2008. 

ADDRESSES: You may submit comments, 

identified by docket number, by one of 

the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments 

via docket number USCBP–2007–0083. 

• Mail: Trade and Commercial 

Regulations Branch, Office of 

International Trade, Customs and 

Border Protection, 1300 Pennsylvania 

Ave., NW., (Mint Annex), Washington, 

DC 20229. 

Instructions: All submissions received 

must include the agency name and 

document number for this proposed 

interpretive rule. All comments received 

will be posted without change to http:// 

www.regulations.gov, including any 

personal information provided. For 

detailed instructions on submitting 

comments and additional information 

on the rulemaking process, see the 

‘‘Public Participation’’ heading of the 

SUPPLEMENTARY INFORMATION section of 

this document. 

Docket: For access to the docket to 

read background documents or 

comments received, go to http:// 

www.regulations.gov. Submitted 

comments may also be inspected during 

regular business days between the hours 

of 9 a.m. and 4:30 p.m. at the Trade and 

Commercial Regulations Branch, 

Regulations and Rulings, Office of 

International Trade, Customs and 

Border Protection, 799 9th Street, NW., 

5th Floor, Washington, DC. 

Arrangements to inspect submitted 

comments should be made in advance 

by calling Mr. Joseph Clark at (202) 572–

8768. 

FOR FURTHER INFORMATION CONTACT: 

Lorrie Rodbart, Valuation and Special 

Programs Branch, Regulations and 

Rulings, Office of International Trade, 

(202) 572–8740. 

SUPPLEMENTARY INFORMATION:

Public Participation 

Interested persons are invited to 

submit written data, views, or 

arguments on all aspects of the 

proposed interpretation. If appropriate 

to a specific comment, the commenter 

should reference the specific portion of 

the proposed interpretation, explain the 

reason for any recommended change, 

and include data, information, or 

authority that support such 

recommended change. 

Background 

Notice of Proposed Interpretation 

On January 24, 2008, a notice was 

published in the Federal Register (73 

FR 4254) informing interested parties 

that Customs and Border Protection 

(CBP) proposed a new interpretation of 

the phrase ‘‘sold for exportation to the 

United States’’ for purposes of applying 

the transaction value method of 

valuation in a series of sales importation 

scenario. Under this proposal, in a 

transaction involving a series of sales, 

the price actually paid or payable for the 

imported goods when sold for 

exportation to the United States is the 

price paid in the last sale occurring 

prior to the introduction of the goods 

into the United States, instead of the 

first (or earlier) sale. As a result, 

transaction value will normally be 

determined on the basis of the price 

paid by the buyer in the United States. 

This proposed interpretation reflects the 

conclusions of the Technical Committee 

on Customs Valuation as set forth in 

Commentary 22.1, entitled ‘‘Meaning of 

the Expression ‘Sold for Export to the 

Country of Importation’ in a Series of 

Sales.’’

The notice of proposed interpretation 

invited public comment on the 


jlentini on PROD1PC65 with NOTICES